ASLAN Pharmaceuticals Appoints Kenneth Kobayashi, MD, as Chief Medical Officer
SINGAPORE, Aug. 03, 2020 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company […]